NCT01310296View on ClinicalTrials.gov

Lofexidine ADME & Mass Balance in Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Normal Healthy Volunteers Will be Treated With Lofexidine to Understand the Absolute Bioavailability and Mass Balance Recovery of the Product
Interventions
DRUG

Lofexidine hydrochloride

Single Dose = Solution containing 400 μg lofexidine HCl and a tracer amount of 14C lofexidine

DRUG

Lofexidine hydrochloride

Single Dose = 200 μg lofexidine in phosphate-buffered saline administered intravenously via infusion pump at a rate of 1 μg/min for 200 min

Trial Locations (1)

78217

Worldwide Clinical Trials, San Antonio

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

USWM, LLC (dba US WorldMeds)

INDUSTRY

NCT01310296 - Lofexidine ADME & Mass Balance in Volunteers | Biotech Hunter | Biotech Hunter